2 / 21
Volume 7, Issue 10 (Suppl)
Gynecol Obstet (Sunnyvale), an open access journal
ISSN: 2161-0932
Gynecology 2017
October 02-04, 2017
Page 24
conference
series
.com
4
th
International Conference on
Gynecology & Obstetrics
October 02-04, 2017 Barcelona, Spain
Greg J Marchand, Gynecol Obstet (Sunnyvale) 2017, 7:10(Suppl)
DOI: 10.4172/2161-0932-C1-021
Successful complete laparoscopic staging of ovarian cancer in a patient with a 17 cm malignant
ovarian tumor
A
47-year-old nulligravid, morbidly obese, Caucasian female had a history of a 6 cm left adnexal cystic mass that had been
followed for greater than two years. During that time, there was no significant change in character of the mass and the
patient’s CA-125 levels remained within normal limits for a pre-menopausal female. The patient had an onset of severe lower
pelvic pain following a vigorous workout and arrived to the Emergency Department complaining of severe primarily lower
abdominal and pelvic pain. Trans-vaginal ultrasound and computed tomography scan revealed a large right-sided complex
adnexal mass. In recent years, the use of electro-mechanical morcellation in gynecological surgeries has become a point
of controversy. The United States Food and Drug Administration released a safety communication in 2014 on the risks of
dissemination of malignancies when using electro-mechanical morcellation. This new technique effectively minimizes these
risks by using blunt instruments to cautiously transfer a large mass into a containment bag for morcellation and removal, while
avoiding rupture of the bag itself. After this patient’s tumor was removed, the remainder of the staging procedure was also able
to be completed laparoscopically, an outcome that can make a very large difference to cancer patients especially. This method
opens up discussion on more widespread use of minimally invasive surgery. If further studies support its efficacy in preventing
tissue dissemination, it has the potential to lead to an increase in candidates for laparoscopy, the removal of larger masses
through smaller holes, and ultimately better outcomes for patients.
Biography
Greg J Marchand is a board certified Ob-Gyn who leads a practice focusing on minimally invasive surgery in Mesa, AZ. He has extensively published his research work in
minimally invasive surgery and has several world records regarding laparoscopic surgical achievements. He is a Research Director in Department of Minimally Invasive
Surgical at Marchand OBGYN. He is graduated fromArizona State University (ASU).
laudius@aol.comGreg J Marchand
Marchand OBGYN Department of Minimally Invasive Surgery, Mesa, USA